PRODUCTS

IN GREECE  /  PROHYPE «  BACK TO "IN GREECE"

Prohype is indicated for the treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate.

Prohype is a specific inhibitor of the enzyme 5α-reductase, which metabolizes testosterone into dihydrotestosterone.

This reduces prostate size, leading to improvement in urinary flow rate and in obstructive symptoms.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Finasteride
  • Film Coated Tablets

  • Tabs 14 x 5mg

  • Benign Prostatic Hyperplasia

Other products in "In Greece"